Chronic Intestinal Pathologies Analytical Cohort at TouLouse

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY

In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and patients who should benefit from digestive examinations as part of a screening oriented either by the patient's family history or following the performance of an immunological screening test ( FIT) in the stool will be studied. The aim of this project is to build a biological collection with associated clinical data for research projects.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or

• Patient with IBD requiring surgical management

• Patient over 18 years old

• Patient able to read and understand the information leaflet

• Patients who have given their consent to participate in the study

• Patients affiliated to a social security system (including AME)

Locations
Other Locations
France
Rangueil University Hospital
RECRUITING
Toulouse
Contact Information
Primary
Barbara Bournet, MD, PhD
bournet.b@chu-toulouse.fr
5 61 32 32 35
Backup
Cindy Canivet
canivet.c@chu-toulouse.fr
5 61 32 20 48
Time Frame
Start Date: 2021-04-29
Estimated Completion Date: 2025-09
Participants
Target number of participants: 300
Treatments
Patient screened or followed-up for IBS or IBD or colorectal cancer
Blood and colon biopsy sampling
Sponsors
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov